Explore | Successful

1 investments found


Synartro develops improved treatments based on patented drug delivery technology and novel uses of drugs with proven safety and efficacy.
Funded SEK 16,977,996
Capital Target SEK 16,977,996
Max. Raise SEK 16,977,996
Min. Raise SEK 10,186,762
Percent of Equity Offered 61%
Valuation of equity SEK 28000000
End Date 26 October 2020
1 Startup Solna
View Investment